Literature DB >> 33951966

Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus.

Naeim Ehtesham1,2, Maryam Zare Rafie3, Emran Esmaeilzadeh4, Mohammad Dehani4, Saeideh Davar5, Meysam Mosallaei1,2, Bahram Pakzad6, Tahereh Ghorashi7, Hossein Darvish8, Mohsen Soosanabadi8.   

Abstract

OBJECTIVE: Nod-like receptor pyrin domain containing 3 (NLRP3) gene encodes an intracellular receptor whose dysregulation in systemic lupus erythematosus (SLE) has been reported in multiple studies. Activation of NLRP3 inflammasome leads to the induction of inflammatory response via cleaving and producing of specific cytokines. In the present study, we assessed the possible association between three functional polymorphisms in this gene and SLE risk in the Iranian population. These variants include two gain of function (rs4612666 and rs10754558) and one loss of function (rs6672995) which are correlated with modulation of expression of NLRP3.
METHODS: A case-control study involving 110 SLE patients and 116 control subjects was undertaken to estimate the frequency of rs4612666, rs10754558, and rs6672995 genotypes using real-time PCR high resolution melting method (HRM).
RESULTS: Our findings revealed significant associations between GG genotype and G allele of rs10754558 with increased risk of SLE (OR for GG genotype= 2.82; 95%CI [1.45-5.46]/OR for G allele= 1.97; 95%CI [1.36-2.87]). Although, no significant associations were recognized between allele and genotype frequencies of rs4612666 and rs6672995 polymorphisms with SLE risk (P > 0.05). Also, our analysis revealed that the C allele in rs4612666 and G allele in rs10754558 was correlated with the severity of disease activity (P < 0.001). Moreover, these common variants were associated with lower age of onset and some clinical symptoms in the patient group, such as skin manifestation, neurological symptom and, renal involvement (P < 0.05).
CONCLUSION: This study demonstrates a substantial association between NLRP3 polymorphisms with increased risk, clinical symptoms, and the severity of disease activity of SLE.

Entities:  

Keywords:  NLRP3 gene; Systemic lupus erythematosus; inflammasome; single nucleotide polymorphisms

Mesh:

Substances:

Year:  2021        PMID: 33951966     DOI: 10.1177/09612033211014273

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  5 in total

1.  A functional microRNA binding site variant in IL-23R gene in systemic lupus erythematosus and rheumatoid arthritis: is there any correlation?

Authors:  Samira Alesaeidi; Saeed Esmaeili Dizghandi; Goli Siri; Meysam Mosallaei; Taiebe Kenarangi; Tahereh Ghorashi; Mohsen Soosanabadi
Journal:  Mol Biol Rep       Date:  2022-10-10       Impact factor: 2.742

Review 2.  Strategies of Targeting Inflammasome in the Treatment of Systemic Lupus Erythematosus.

Authors:  Yaling Liu; Xinyu Tao; Jinhui Tao
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

Review 3.  The Role of NLRP3 Inflammasome in Lupus Nephritis.

Authors:  Camila Barbosa Oliveira; Camilla Albertina Dantas Lima; Gisele Vajgel; Paula Sandrin-Garcia
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

4.  Impact of Single Nucleotide Polymorphism in the ANKRD55 Gene on Occurrence and Clinical Characteristics of Rheumatoid Arthritis.

Authors:  Rasoul Salehi; Mina Motaghi; Amirhossein Salehi; Hadi Karimzadeh; Bahram Pakzad
Journal:  Avicenna J Med Biotechnol       Date:  2022 Jul-Sep

5.  Single Nucleotide Polymorphism rs6445975 in the PXK Gene Is Correlated with Susceptibility and Clinical Characteristics of Systemic Lupus Erythematosus.

Authors:  Mansour Karimifar; Nafiseh Sereshti; Rasoul Salehi; Maryam Mousavi; Hadi Karimzadeh; Amirhossein Salehi; Bahram Pakzad
Journal:  Iran J Public Health       Date:  2022-08       Impact factor: 1.479

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.